RecruitingNot ApplicableNCT07468409

ORYOM Robotic Surgical System in Cataract Surgery

Single-site, Open-label, Prospective Feasibility Study Performed Using the ORYOM™ Robotic Surgical System in Cataract Surgery Procedures


Sponsor

ForSight Robotics Ltd

Enrollment

20 participants

Start Date

Feb 20, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, open-label clinical study designed to evaluate the performance and safety of the ORYOM Robotic Surgical System during cataract surgery.


Eligibility

Min Age: 55 YearsMax Age: 80 Years

Inclusion Criteria5

  • Patient aged 55 to 80 years
  • Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol
  • Patients are scheduled to undergo cataract surgery
  • Clear intraocular media, other than cataract
  • Pupil dilate according to stand of care

Exclusion Criteria7

  • Prior ocular surgery or trauma in the study eye
  • Polar cataract in the study eye
  • Zonular instability or significant anterior segment abnormalities
  • Active ocular infection or uveitis
  • Pseudoexfoliation (PXF) syndrome in either eye
  • ASA Physical Status Classification \> 3
  • Participation in another clinical trial within 30 days

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEORYOM™ Robotic Surgical System

The ORYOM Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery.


Locations(1)

Asian Eye Instiitute

Makati City, National Capital Region, Philippines

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07468409


Related Trials